Larré Stéphane, Kanso Chaker, De La Taille Alexandre, Hoznek Andras, Vordos Dimitrios, Yiou René, Abbou Clément-Claude, Salomon Laurent
Department of Urology, Henri Mondor University Hospital, Créteil, France.
World J Urol. 2008 Dec;26(6):611-5. doi: 10.1007/s00345-008-0306-8. Epub 2008 Jul 16.
To report the intermediate oncological results of laparoscopic radical nephrectomy by retroperitoneal approach.
From 1995 to 2006, 146 consecutive patients with removal of a malignant kidney tumor by laparoscopic retroperitoneal radical nephrectomy were analysed retrospectively. The patients were followed clinically, biologically and radiologically every 6 months. Disease-free survival and specific survival were determined among patients free of metastasis at surgery.
Patient's average age was 61.1 years (25-85). The pathology of these cancers were: 108 clear cell carcinomas, 26 papillary carcinomas, 10 chromophobe carcinomas, and 2 miscellaneous. The T stage were: 105 pT1, 12 pT2, and 29 pT3 (TNM 2002). The Fuhrman grade were: I in 23 cases, II in 70 cases, III in 40 cases, and IV in 9 cases. The surgical margins were positive in 2. No port site recurrence occurred. The average follow-up was 35.4 months (1-137). Five patients had metastatic disease at presentation. Tumor progression was observed among 19 patients, in the form of a local (1) or remote recurrence (18). Fourteen patients died, including 7 because of their tumor. The disease-free survival at 5 and 10 years, were respectively 87.3 and 73.2%, and the cancer-specific survival were 96.2 and 92.0%, respectively.
The laparoscopic retroperitoneal radical nephrectomy offers intermediate oncological results compatible with appropriate carcinological efficacy.
报告经腹膜后途径腹腔镜根治性肾切除术的中期肿瘤学结果。
回顾性分析1995年至2006年期间连续146例行腹腔镜腹膜后根治性肾切除术切除恶性肾肿瘤的患者。每6个月对患者进行临床、生物学和影像学随访。在手术时无转移的患者中确定无病生存率和特异性生存率。
患者平均年龄为61.1岁(25 - 85岁)。这些癌症的病理类型为:108例透明细胞癌、26例乳头状癌、10例嫌色细胞癌和2例其他类型。T分期为:105例pT1、12例pT2和29例pT3(TNM 2002)。Fuhrman分级为:I级23例、II级70例、III级40例和IV级9例。2例手术切缘阳性。未发生切口部位复发。平均随访时间为35.4个月(1 - 137个月)。5例患者就诊时已有转移性疾病。19例患者出现肿瘤进展,表现为局部复发(1例)或远处复发(18例)。14例患者死亡,其中7例死于肿瘤。5年和10年的无病生存率分别为87.3%和73.2%,癌症特异性生存率分别为96.2%和92.0%。
腹腔镜腹膜后根治性肾切除术提供了与适当的肿瘤学疗效相符的中期肿瘤学结果。